HCC Current Controversies

Back to Package

This recording is part of the SIO2021 Conference Recordings Bundle. Click here to purchase the full bundle and save!

 MODERATORLaura Crocetti, MD, PhD, EBIR
Is Biospy Dead in the Era of LIRADS? Claude Sirlin, MD
Changing landscape of systemic therapy for HCC Robin Kate Kelley, MD
Transplantation Triage Andy Bonham, MD
Transarterial Therapies for HCC: Have We Reached Consensus?/Personalized Dosimetry for Y90 Dave Liu, MD
Is SABR Definitive Treatment for HCC? Laura Dawson, MD
Is Ablation Definitive Treatment for HCC? Laura Crocetti, MD, PhD, EBIR
957019 Delayed Treatment Response after Radiation Segmentectomy: Is 3 months follow up enough? Shanmukha Srinivas, MD
Q&AAll Faculty


HCC Current Controversies
Open to view video.
Open to view video.